Table 1.
Correlation of circPICALM levels and clinical parameters.
| Characteristics | circPICALM expression |
|||
|---|---|---|---|---|
| No. (%) | Low (%) | High (%) | P-value | |
| Gender | ||||
| Male | 139 (82.7) | 39 (28.1) | 100 (71.9) | 0.290 |
| Female | 29 (17.3) | 11 (37.9) | 18 (62.1) | |
| Age | ||||
| <65 | 86 (51.2) | 21 (24.4) | 65 (75.6) | 0.121 |
| ≥65 | 82 (48.8) | 29 (35.4) | 53 (64.6) | |
| Tumour size | ||||
| <3 cm | 140 (83.3) | 44 (31.4) | 96 (68.6) | 0.291 |
| ≥3 cm | 28 (16.7) | 6 (21.4) | 22 (78.6) | |
| Pathology stage | ||||
| pTa-pT1 | 79 (47.0) | 12 (15.2) | 67 (84.8) | 0.000⁎⁎ |
| pT2-T4 | 89 (53.0) | 38 (42.7) | 51 (57.3) | |
| Grade | ||||
| Low | 35 (20.8) | 4 (11.4) | 31 (88.6) | 0.008⁎⁎ |
| High | 133 (79.2) | 46 (34.6) | 87 (65.4) | |
| Lymphatic metastasis | ||||
| Yes | 27 (16.1) | 20 (74.1) | 7 (25.9) | 0.000⁎⁎ |
| No | 141 (83.9) | 30 (21.3) | 111 (78.7) | |
| Total | 168 | 50 | 118 | |
Chi-square test.
⁎⁎
P < .01.